ACCURACY a phase (P) II trial of AL101, a pan-Notch inhibitor, in recurrent/metastatic (R/M) adenoid cystic carcinoma (ACC) patients (pts) with Notch activating mutations (Notch act mut): Preliminary safety and efficacy data Meeting Abstract
| Authors: | Ferrarotto, R.; Ho, A.; Wirth, L. J.; Muzaffar, J.; Rodriguez, C.; Dekel, E.; Walker, R. M.; Nadri-Shay, C.; Vergara-Silva, A. |
| Abstract Title: | ACCURACY a phase (P) II trial of AL101, a pan-Notch inhibitor, in recurrent/metastatic (R/M) adenoid cystic carcinoma (ACC) patients (pts) with Notch activating mutations (Notch act mut): Preliminary safety and efficacy data |
| Meeting Title: | 44th ESMO Congress (ESMO 2019) |
| Journal Title: | Annals of Oncology |
| Volume: | 30 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2019 Sep 27-Oct 1 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2019-10-01 |
| Start Page: | mdz252.040 |
| Language: | English |
| ACCESSION: | WOS:000491295503196 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdz252.040 |
| Notes: | Meeting Abstract: 1148P -- Appears on pages v465-v466 of the abstract book -- Source: Wos |
